Header Logo

Connection

JOHN KIRKWOOD to Herpesvirus 1, Human

Back to Details
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Herpesvirus 1, Human.
JOHN KIRKWOOD
Connection Strength
0.203
Herpesvirus 1, Human
  1. Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma. J Clin Oncol. 2023 01 20; 41(3):528-540.
    View in: PubMed
    Score: 0.203
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.